Colleen Proctor

AstraZeneca’s global biologics research and development arm MedImmune completed its acquisition of US-based Amplimmune for $225M plus $275M based on predetermined milestones

London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that on 4 October MedImmune, its global biologics research and development arm,…

11 years ago

AstraZeneca: temporary injunction against the US launch of Hanmi’s 505(b)2 NDA esomeprazole strontium lifted by Court of Appeals for the Federal Circuit (CAFC)

London, United Kingdom, 10-10-2013 — /EuropaWire/ — AstraZeneca today announced that the US Court of Appeals for the Federal Circuit (CAFC) lifted…

11 years ago